February 24, 2025
CivicaScript® Lowers Price of its Generic Abiraterone Tablets
The price cut comes at a time when other pharmaceutical manufacturers have announced price increases for many of their medicines in 2025. Volume discounts passed along to members and to patients is proof that the CivicaScript model is working.
Media Coverage
March 6, 2025
Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in United States
“Our partnership with Biocon Biologics for Aspart drug substance supply will allow us to deliver on our important mission and help people who need access to Insulin Aspart.”
Media Coverage
April 10, 2025
CivicaScript® Launches Droxidopa, Drives Savings for Patients and Payers
Media Coverage
May 21, 2025
NEJM Catalyst Analysis Takes CivicaScript’s Mission from Proof-of-Concept to Proof
“Despite facing resistance from entrenched industry structures, CivicaScript’s approach demonstrates the potential to reshape the pharmaceutical supply chain, offering a sustainable and scalable model for improving generic drug affordability.”
Media Coverage
May 28, 2025
Leading Nonprofit Healthcare Provider Avera Joins Civica
“Civica offers us an additional tool to ensure stability of supply and predictability of cost for medications, allowing us to focus our time on our priority: our patients.”
Media Coverage
June 23, 2025
Civica Board Chair Dan Liljenquist Honored by Healthcare Financial Management Association
Media Coverage
June 24, 2025
CivicaScript® Launches Low-Cost Multiple Sclerosis Treatment, Creates Significant Savings
“Today’s launch is yet another step in our journey to make necessary medications more affordable for the patients who need them,” said CivicaScript President Brent J. Eberle.
Media Coverage
June 2025
Civica by the Numbers
Delivering vital medications
219M
vials or syringesof essential
generic medications
Helping to treat millions of patients
Solving critical drug shortages
70
Genericmedications
available
from Civica
Building innovative partnerships
